4//SEC Filing
Peterson Amy C. 4
Accession 0001567619-22-002525
CIK 0001501989other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:53 PM ET
Size
7.6 KB
Accession
0001567619-22-002525
Insider Transaction Report
Form 4
Peterson Amy C.
EVP, Chief Development Officer
Transactions
- Award
Common Stock
2022-02-02+40,000→ 46,421 total - Award
Stock Option (Right to Buy)
2022-02-02+200,000→ 200,000 totalExercise: $4.13Exp: 2032-02-01→ Common Stock (200,000 underlying)
Footnotes (3)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F2]Includes 40,000 RSUs.
- [F3]1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001682735
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:53 PM ET
- Size
- 7.6 KB